Australia vs Northern Africa and Western Asia: Proportion of the target population who received the final dose of
Australia
73.0%
in 2024
Northern Africa and Western Asia
2.0%
in 2024
Australia rank
36th
Northern Africa and Western Asia rank
35th
Proportion of the target population who received the final dose of over time
- Australia
- Northern Africa and Western Asia
How they compare
Australia currently reports 73.0% against 2.0% in Northern Africa and Western Asia, a difference of 71.0%.
That makes Australia's figure about 36.5 times Northern Africa and Western Asia's.
Across all 11 years both countries report, Australia has been ahead every year.
Australia ranks 36th and Northern Africa and Western Asia ranks 35th of 107 countries.
Australia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Northern Africa and Western Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.7% | 1.0% | 70.7% | Australia |
| 2020s | 66.6% | 1.8% | 64.8% | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Australia or Northern Africa and Western Asia?
- Australia, at 73.0% against 2.0% in Northern Africa and Western Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Australia and Northern Africa and Western Asia?
- 71.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Northern Africa and Western Asia?
- 11 years are reported by both, from 2014 to 2024.
- How do Australia and Northern Africa and Western Asia rank globally for proportion of the target population who received the final dose of?
- Australia ranks 36th and Northern Africa and Western Asia ranks 35th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.